Skip to Main content Skip to Navigation
Journal articles

Of chloroquine and COVID-19

Abstract : Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.
Complete list of metadata
Contributor : Myriam Bodescot Connect in order to contact the contributor
Submitted on : Thursday, March 26, 2020 - 10:54:03 AM
Last modification on : Wednesday, November 3, 2021 - 9:46:52 AM

Links full text




Franck Touret, Xavier de Lamballerie. Of chloroquine and COVID-19. Antiviral Research, Elsevier Masson, 2020, 177, pp.104762. ⟨10.1016/j.antiviral.2020.104762⟩. ⟨inserm-02519612⟩



Les métriques sont temporairement indisponibles